Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Shares Issued (2020 - 2025)

Exagen (XGN) has disclosed Shares Issued for 7 consecutive years, with $18.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued changed N/A year-over-year to $18.4 million, compared with a TTM value of $18.6 million through Dec 2025, changed N/A, and an annual FY2025 reading of $18.6 million, changed N/A over the prior year.
  • Shares Issued was $18.4 million for Q3 2025 at Exagen, up from $1000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $69.1 million in Q2 2021 and bottomed at -$69.1 million in Q3 2021.
  • Average Shares Issued over 5 years is $1.5 million, with a median of $104000.0 recorded in 2024.
  • The sharpest move saw Shares Issued crashed 575633.33% in 2021, then soared 902.08% in 2022.
  • Year by year, Shares Issued stood at -$48000.0 in 2021, then skyrocketed by 902.08% to $385000.0 in 2022, then crashed by 34.55% to $252000.0 in 2023, then tumbled by 141.27% to -$104000.0 in 2024, then surged by 17819.23% to $18.4 million in 2025.
  • Business Quant data shows Shares Issued for XGN at $18.4 million in Q3 2025, $1000.0 in Q2 2025, and $198000.0 in Q1 2025.